Ian Chan is the founder of Atlantic Coastal Acquisition Corp. II. Atlantic Coastal Acquisition Corp. II has raised $10M in total funding. Latest round: IPO.
Ian Chan is the CEO and co-founder of Abpro, a biotechnology company based in Woburn, Massachusetts. Abpro specializes in developing next-generation antibody therapies to treat severe and life-threatening diseases. The company is set to become publicly traded via a merger with Atlantic Coastal Acquisition Corp. II, a transaction that values Abpro at $725 million and aims to advance its drug pipeline to clinical trials. Abpro also has a partnership with Celltrion.
Full founder directory · Investor directory · Company funding database · Fundraising library